September 21, 2020 10:27 AM EDT

News briefing: Bausch Health closing in on deal to acquire Allegro assets; PharmAbcine strikes deal with Samsung Biologics to develop antibody program

Bausch Health is closing in on a deal that would allow it to buy out all of Allegro Ophthalmics’ eye …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

News brief­ing: Bausch Health clos­ing in on deal to ac­quire Al­le­gro as­sets; PharmAbcine strikes deal with Sam­sung Bi­o­log­ics to de­vel­op an­ti­body pro­gram